Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
0.256 %
$ 349 M
Market Cap
-8.89
P/E
TRVI - FREE CASH FLOW
Free Cash Flow TRVI - Trevi Therapeutics, Inc.
-31.8 M
LAST VALUE
-4.89%
2 YEAR CAGR
-11.54%
5 YEAR CAGR
0.00%
10 YEAR CAGR